...Eli ...r $6.5 billion. Lilly's $70-a-share bid for ImClone, the biotechnology company controlled by billionaire Carl Icahn, tops Bristol-Myers Squibb Co.'s hostile bid of $62 a share. (Source: ...

43

Eli Lilly will acquire ImClone for $70/share and eBays job cuts will affect about 1,000 employees, reports CNBCs David Faber

43

Insight on ImClone's mystery bidder, with CNBC's Mike Huckman

Eli Lilly completes a deal to buy ImClone, reports CNBC's Mike Huckman

Eli Lilly buys imclone. Eli Lilly CEO, John Lechleiter talks about the deal to purchase Imclone for $70 per share.